Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2000
06/20/2000US6077686 Nucleotide and amino acid sequences of protein expressed in adult brain; mediates tyrosine kinases in the nervous system such as receptors for nerve growth factors; antitumor agents; treatment/diagnosis of nervous system disorders
06/20/2000US6077685 Tumor suppressor merlin and antibodies thereof
06/20/2000US6077680 Inhibiting kv1 potassium channel activity in a lymphocyte of an animal by administering polypeptide of specific amino acid sequence; for treatment of autoimmune disorders
06/20/2000US6077679 Herpes virus proteinase and method of assaying
06/20/2000US6077677 Amino acid sequence; bactericides; prophylactic agents; diagnosis; drug screening
06/20/2000US6077676 Single-chain polypeptides comprising troponin I and troponin C
06/20/2000US6077675 Drug screening by contacting compound with recombinant cell which expresses a nucleic acid encoding the receptor and monitoring for binding or modulation of receptor; anticonvulsants; analgesics; cognition enhancers
06/20/2000US6077666 Receptor identification method
06/20/2000US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/20/2000US6077662 Virus-like particles, methods and immunogenic compositions
06/20/2000US6077661 Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid
06/20/2000US6077519 Antitumor vaccine comprising t-cell epitopes recovered through acid elution from patient's viable resected tumor tissue and as adjuvant dendritic cells and/or cytokines
06/20/2000US6077518 Cloning of mite allergens
06/20/2000US6077517 House dust mite allergen, Der p VII, and uses thereof
06/20/2000US6077515 Vaccine comprising whole cells from a purified culture of flagella-less b. burgdorderi having phenotypic characteristics of atcc no. 55131 and a carrier
06/20/2000US6077514 Characterized in that the viruses have a codon encoding an amino acid in the f protein chosen from specified amino acids at their amino acid numbers; temperature sensitive rsv phenotype; immunizing
06/20/2000US6077511 Antigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection
06/20/2000US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
06/20/2000US6077509 Given amino acid sequences that are immunodominant in humans suffering from multiple sclerosis
06/20/2000US6077507 Method of making a composition comprising a fibrin monomer
06/20/2000CA2186875C Gene imparting flocculability to yeast and gene product
06/20/2000CA2001303C Endothelin dna and use thereof
06/20/2000CA1341033C Precursor protein of apc polypeptide, dna coding for this, and diagnostic use of the dna and of the protein
06/20/2000CA1341032C Anticoagulant peptides
06/20/2000CA1341030C Protein active in humoral hypercalcemia of malignancy-pthrp
06/20/2000CA1341029C Peptidase inhibitors
06/17/2000CA2292474A1 Process for dissolving albumin flakes in a liquid and arrangement for carrying out the process
06/15/2000WO2000034784A1 Protein scaffolds for antibody mimics and other binding proteins
06/15/2000WO2000034782A1 Flint compositions and uses thereof
06/15/2000WO2000034780A2 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
06/15/2000WO2000034529A1 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey
06/15/2000WO2000034526A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034524A1 Compositions and methods relating to a new cell cycle regulating gene
06/15/2000WO2000034511A2 Aβ-PEPTIDE SCREENING ASSAY
06/15/2000WO2000034505A1 Expression system for factor viii
06/15/2000WO2000034498A1 Two-step immunization procedure against chlamydia infection
06/15/2000WO2000034496A2 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
06/15/2000WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000WO2000034493A2 Regulatory sequences of the mouse villin gene - use in transgenesis
06/15/2000WO2000034492A1 Regulatory sequences of the mouse villin gene - use in transgenesis
06/15/2000WO2000034490A1 A method for manufacturing glycoproteins having human-type glycosylation
06/15/2000WO2000034489A1 Major basic protein deficient animals
06/15/2000WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000WO2000034482A2 Novel compounds derived from neisseria meningitidis
06/15/2000WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS)
06/15/2000WO2000034480A1 Polypeptides and polynucleotides 'basb040' from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides
06/15/2000WO2000034479A1 Genes of resistance against diseases induced by microorganism belonging to magnapothe grisea, plants transformed by the genes and process for producing the same
06/15/2000WO2000034478A1 Betacellulin modification
06/15/2000WO2000034477A2 Neuron-associated proteins
06/15/2000WO2000034476A2 Nucleic acid molecules of shrimp
06/15/2000WO2000034475A2 Grnf4, a gdnf-related neurotrophic factor
06/15/2000WO2000034474A2 Growth factor homolog zvegf3
06/15/2000WO2000034473A2 Seven transmembrane domain receptor zsig56
06/15/2000WO2000034472A1 Spermatogenesis protein
06/15/2000WO2000034471A1 Human neural system growing-associated genes and the proteins encoded by the genes
06/15/2000WO2000034469A1 Compositions and methods for altering cell migration
06/15/2000WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders
06/15/2000WO2000034466A1 Cervical cancer treatment
06/15/2000WO2000034465A2 HEAT SHOCK GENES AND PROTEINS FROM NEISSERIA MENINGITIDIS, CANDIDA GLABRATA AND $i(ASPERGILLUS FUMIGATUS)
06/15/2000WO2000034464A1 Method for yeast screening of protein-kinase modulators specific of superior eukaryotic cells, including human cells
06/15/2000WO2000034461A2 Compositions and methods of modulating cholesterol metabolism
06/15/2000WO2000034453A1 PURIFICATION OF α1-PROTEINASE INHIBITOR
06/15/2000WO2000034445A2 Live attenuated venezuelan equine encephalitis vaccine
06/15/2000WO2000034441A1 CONVERSION OF LAMININ 5 TO A MIGRATORY SUBSTRATE BY PROTEOLYSIS OF THE η2 CHAIN THEREOF
06/15/2000WO2000034438A2 Method for constructing libraries of phenotypic profiles
06/15/2000WO2000034436A2 Facs assisted methods for introducing individual chromosomes into cells
06/15/2000WO2000034435A2 Cis-element reporter constructs and uses thereof
06/15/2000WO2000034336A1 A method for detecting neuronal cell damage by quantification of map-2 levels in biological fluids
06/15/2000WO2000034335A2 'death domain' containing receptors
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034333A1 Novel g protein-coupled receptor
06/15/2000WO2000034332A1 Glp-1 analogues
06/15/2000WO2000034331A2 Analogues of glp-1
06/15/2000WO2000034329A2 Differentiation signal
06/15/2000WO2000034328A1 Tpaaoh04: human g protein sara gene
06/15/2000WO2000034326A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034325A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034324A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034323A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034322A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034321A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034320A1 Fluorescent proteins from non-bioluminiscent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034319A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034318A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034317A2 Method for reducing immunogenicity of proteins
06/15/2000WO2000034316A1 Era complexes and uses thereof
06/15/2000WO2000034313A1 Procollagen c-proteinase inhibitors
06/15/2000WO2000034310A1 Purified and isolated serine-threonine kinase receptors associated protein
06/15/2000WO2000034309A1 Cloning and characterization of a cd2 binding protein (cd2bp2)
06/15/2000WO2000034308A2 Protein transduction system and methods of use thereof
06/15/2000WO2000034304A1 Eosinophil-specific expression of transgenes
06/15/2000WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1')
06/15/2000WO2000034236A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
06/15/2000WO2000033880A2 Conjugate used for enriching in neuronal cells
06/15/2000WO2000033872A2 Method of and compositions for immunization with the pseudomonas v antigen
06/15/2000WO2000033866A1 Pharmaceutical compositions containing insulin
06/15/2000WO2000033865A1 Methods of inhibiting ectopic calcification
06/15/2000WO2000033791A2 Co-factors for trophic factors, and methods of use thereof
06/15/2000WO2000033658A1 Composition and method for regulation of body weight and associated conditions
06/15/2000WO2000012678A3 Staphylococcus aureus genes and polypeptides